PwC Taiwan Bio Group has been providing biotech companies a comprehensive solution with both value and trust. With our expertise in assurance, tax, and advisory, we have built our leading market position while supporting our clients to build competitive advantages and thrive. Biotechnology has been identified as one of the “eight most important technologies” by Taiwan’s government. The newly launch of the “Promotion of Innovation in the Biopharma Industry” scheme by Taiwan’s government in 2016 has further bringing in the industry a new era.
PwC Bio Insights keeps you updated with the latest industrial news and market trend for biotechnology. By leveraging the talent of PwC global network, we provide you information essential to doing business in Taiwan and also exploring worldwide opportunities. We hope you find this paper a good read and related to issues raised in your organization. For more information, please contact Audrey Tseng.